Please login to the form below

Not currently logged in
Email:
Password:

NCCN bolsters its Oncology Research Programme

Uses iEnvision to manage the programme’s projects

Envision Pharma GroupAs a way to better support and manage multiple research projects, The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 27 cancer centres, has implemented a new web-based software programme into their Oncology Research Programme (ORP).

Known as iEnvision, the programme was developed by scientific communications and technology solutions company Envision Pharma Group to support medical affairs-related programmes of activity.

In this particular case, iEnvision will support investigator-led studies for the NCCN’s ORP, which supports research through collaborations with pharmaceutical companies by drawing on the expertise of investigators from cancer centres.

Susan Most, director of clinical operations for the NCCN ORP, said: “Switching to Envision’s web-based system has allowed the ORP to streamline our process for managing proposals and investigator-initiated clinical trials, making it easier to manage research that will improve patients’ quality-of-life and reduce cancer-related deaths.

“Envision worked with us to adapt their platform to meet the specific needs of our applicants, reviewers and institutions and we’re now able to accept and review proposals in a more efficient, user-friendly manner.”

The NCCN plans to use the system to process around 50 proposal submissions and manage 70 active studies annually.

Additionally, the system will enable the management of studies in an ‘efficient’ manner, facilitating grant applicants, NCCN staff and peer reviewers and the ability to upgrade and make changes to the system each year.

Kelli Walker, director of platform strategy for Envision, said: “We are pleased to have been able to provide the adaptation of our industry standard study management iEnvision module for NCCN, supporting their industry-wide coordination of important, indepdent oncology research.”

Article by
Gemma Jones

28th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics